Call for Corn Bids

Graettinger, IA

Lee Carpenter

(712) 859-3663 Ext. 202

Lake Mills, WI

Pete Wollin

(920)648-2377 Ext. 18

    

 

 

Thursday, March 21, 2019  
 
Weather |  Futures |  Futures Markets |  Market News |  Headline News |  DTN Ag Headlines |  Charts |  Portfolio |  Options |  Corn News |  Soybeans News 
Home
About Us
Login/Register
Delayed Futures
Discount Schedule
Local Grainbids
Newsletters
USDA Reports
Calendar
LDP
Daily Commentary
Feedback
Admin Login
Cash Bids
 
 
Printable Page Headline News   Return to Menu - Page 1 2 3 5 6 7 8 13
 
 
Tech Leads Stocks Up Early Thursday    03/21 09:58

   U.S. stocks moved broadly higher in early trading on Wall Street Thursday as 
technology stocks offset declines in the banking sector.

   NEW YORK (AP) -- U.S. stocks moved broadly higher in early trading on Wall 
Street Thursday as technology stocks offset declines in the banking sector.

   Apple rose 2.8 percent as it continues to announce new products. Olive 
Garden owner Darden Restaurants soared 6.4 percent after reporting earnings 
that were far better than analysts were expecting.

   Biogen, a major biotechnology company, took a 29 percent nosedive after 
stopping a trial for an Alzheimer's drug. Other health care stocks also fell. 
JPMorgan led a decline in banks with a loss of 1.8 percent.

   Bond prices continued to rise, sending yields lower, a day after the Federal 
Reserve said it expected the economy to slow down and that it no longer 
expected to raise interest rates this year.

   KEEPING SCORE: The Dow Jones Industrial Average rose 62 points, or 0.2 
percent, to 25,806 as of 10:20 a.m. The S&P 500 index rose 0.3 percent and the 
Nasdaq composite rose 0.4 percent.

   BIOGEN BOMBS: The biotechnology giant plunged after the company halted 
development of a highly anticipated Alzheimer's drug. The company and its 
partner determined that the drug would likely be ineffective.

   Like its peers, the drugmaker spends heavily on research and development in 
the hopes that revenue from a successful drug will make up for the costs.

   GUESS NOT: Clothing retailer Guess gave investors a disappointing 
fourth-quarter report and forecast, sending shares 14.5 percent lower.

   The company's fourth-quarter profit and revenue both came up short of 
forecasts. Its profit forecast for the year also fell far shy of Wall Street's 
expectations. 


(BE)

 
 
Copyright DTN. All rights reserved. Disclaimer.
Powered By DTN